ÂÜÀòÂÒÂ×

Gayle Bresnahan is a Senior Director, Clinical Operations at Angiocrine Bioscience, Inc. Gayle has extensive experience in clinical operations and has held various roles at companies such as Travere Therapeutics, Intercept Pharmaceuticals, Halozyme Therapeutics, and Ambit Biosciences Corporation. Currently, Gayle is managing several Phase 3 global clinical trials in multiple countries. Prior to their current position, Gayle held roles at Dexcom, Gen Probe, Vical, and Quintiles.